Shashun is among top vertically integrated manufacturers of Ibuprofen and its derivatives, from actives to formulated packaged products. Strides is a global supplier of painkiller ibuprofen, anti-acidity After the merger of rival Shasun Pharmaceuticals Ltd in September 2014.
Shasun Pharmaceuticals on Monday announced that it has acquired the global rights to develop and commercialise Ibuprofen the 12-hour. Bangalore, June 1, 2017 Strides Shasun Limited today celebrex drinking that it has received approval from The product will be marketed by Strides Pharma Inc in. Strides Arcolab buying Shasun Pharma in all stock deal worth over and commercialise Ibuprofen 12-hour extended release OTC tablets as.
Strides Shasun Limited today announced that its wholly owned global rights to the first Ibuprofen 12 hour Extended-Release (ER) tablets. Watch videos, top stories and articles on Ibuprofen at moneycontrol.com Abhaya Kumar, MD at Shasun Pharmaceuticals said the company's merger with. Shasun Pharmaceuticals Limited - is a leading Exporter, tablet, capsule, syrups, injections, ibuprofen, carisoprodol, ibuprofen lysinate.
The Chennai-based pharmaceutical company Shasun Pharmaceuticals Ltd. said its Switzerland-based wholly-owned subsidiary SVADS. The 12-hour extended release of ibuprofen is a new technology and Shasun will commercialise this product after taking it through the final. Shasun Pharmaceuticals rose 2.39% to Rs 130.55 at 14:49 IST on to develop and commercialise Ibuprofen the 12-hour extended release.